Mycobacterium ulcerans infection in Brazil

dos Santos, Vitorino M; Noronha, Flávio L; Vicentina, Érica C; Lima, Camila C

Topics

To the Editor: Recent articles in the Journal referred to clinical characteristics of lesions caused by Mycobacterium ulcerans in Australia, and to recommendations and challenges in their management.1,2,3

1 Department of Internal Medicine, Armed Forces Hospital, Brasilia, DF, Brazil.
2 Catholic University of Brasilia, Brasilia, DF, Brazil.

Correspondence: vitorinomodesto@gmail.com

1. Asiedu K, Wansbrough-Jones M. Mycobacterium ulcerans infection (Buruli or Bairnsdale ulcer): challenges in developing management strategies. Med J Aust 2006; 186: 55-56. <MJA full text>
2. Johnson PDR, Hayman JA, Quek TY, et al. Consensus recommendations for the diagnosis, treatment and control of Mycobacterium ulcerans infection (Bairnsdale or Buruli ulcer) in Victoria, Australia. Med J Aust 2007; 186: 64-68. <MJA full text>
3. Lavender CJ, Senanayake SN, Fyfe JAM, et al. First case of Mycobacterium ulcerans disease (Bairnsdale or Buruli ulcer) acquired in New South Wales. Med J Aust 2006; 186: 62-63. <MJA full text>
4. van der Werf TS, Stienstra Y, Johnson RC, et al. Mycobacterium ulcerans disease. Bull World Health Organ 2005; 83: 785-791.
5. Portaels F, Aguiar J, Debacker M, et al. Mycobacterium bovis BCG vaccination as prophylaxis against Mycobacterium ulcerans osteomyelitis in Buruli ulcer disease. Infect Immun 2004; 72: 62-65.

Online responses are no longer available. Please refer to our instructions for authors page for more information.